{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T22:10:47Z","timestamp":1760825447148,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T00:00:00Z","timestamp":1628899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jocn.2021.07.025","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T11:54:03Z","timestamp":1627473243000},"page":"313-318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Unclassified subtype of Guillain-Barr\u00e9 syndrome is associated with quick recovery"],"prefix":"10.1016","volume":"91","author":[{"given":"Keiko","family":"Ohnari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumasa","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Mafune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Kusunoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2021.07.025_b0005","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps","volume":"15","author":"Leonhard","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jocn.2021.07.025_b0010","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/brain\/awt285","article-title":"Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Briton criteria","volume":"137","author":"Fokke","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2021.07.025_b0015","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1046\/j.1468-1331.2003.00683.x","article-title":"Guillain-Barr\u00e9 syndrome in southern Taiwan: clinical features, prognosis factors and therapeutic outcomes","volume":"10","author":"Cheng","year":"2003","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jocn.2021.07.025_b0020","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4103\/0972-2327.82793","article-title":"Clinical feature and prognosis with Guillain-Barr\u00e9 syndrome","volume":"14","author":"Akbayram","year":"2011","journal-title":"Ann Indian Acad Neurol"},{"key":"10.1016\/j.jocn.2021.07.025_b0025","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/jnnp-2011-301882","article-title":"Outcome and its predictor in Guillain-Barr\u00e9 syndrome","volume":"83","author":"Rajabally","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2021.07.025_b0030","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1212\/WNL.48.3.695","article-title":"Patterns of recovery in the Guillain-Barr\u00e9 syndromes","volume":"48","author":"Ho","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2021.07.025_b0035","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1212\/01.WNL.0000081231.08914.A1","article-title":"Differences in pattern of progression in demyelinating and axonal Guillain-Barr\u00e9 syndromes","volume":"61","author":"Hiraga","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2021.07.025_b0040","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S1474-4422(06)70603-2","article-title":"Clinical and electrophysiological predictors of respiratory failure in Guillain-Barr\u00e9 syndrome: a prospective study","volume":"5","author":"Durand","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jocn.2021.07.025_b0045","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.clinph.2013.03.025","article-title":"Nodo-paranodopathy: Beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies","volume":"124","author":"Uncini","year":"2013","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.jocn.2021.07.025_b0050","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/glycob\/cwp027","article-title":"Antiganglioside antibodies and their pathophysiological effects on Guillain-Barr\u00e9 syndrome and related disorders\u2013a review","volume":"19","author":"Kaida","year":"2009","journal-title":"Glycobiology"},{"key":"10.1016\/j.jocn.2021.07.025_b0055","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1136\/jnnp.2010.208538","article-title":"Pitfalls in electrodiagnosis of Guillain-Barr\u00e9 syndrome subtypes","volume":"81","author":"Uncini","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2021.07.025_b0060","doi-asserted-by":"crossref","unstructured":"Albert\u00ed MA, Alentorn A, Mart\u00ednez-Yelamos S, Martinez-Matos JA, Povedano M, Montero J, et al. Very early electrodiagnostic findings in Guillain-Barr\u00e9 syndrome. J Peripher Nerv Syst 2011;16:136-42. https:\/\/doi.org\/10.1111\/j.1529-8027.2011.00338.x","DOI":"10.1111\/j.1529-8027.2011.00338.x"},{"key":"10.1016\/j.jocn.2021.07.025_b0065","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000494261","article-title":"Very early neurophysiological study in Guillain-Barr\u00e9 syndrome","volume":"80","author":"Jin","year":"2018","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jocn.2021.07.025_b0070","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/brain\/118.3.597","article-title":"Guillain-Barr\u00e9 syndrome in northern China. Relation to Campylobacter jejuni infection and anti-glycolipid antibodies","volume":"118","author":"Ho","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2021.07.025_b0075","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/jnnp-2014-307815","article-title":"Electrophysiological diagnosis of Guillain-Barr\u00e9 syndrome subtype: could a single study suffice?","volume":"86","author":"Rajabally","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2021.07.025_b0080","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.410440512","article-title":"Electrophysiological classification of Guillain-Barr\u00e9 syndrome: clinical associations and outcome","volume":"44","author":"Hadden","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2021.07.025_b0085","doi-asserted-by":"crossref","unstructured":"Criteria for diagnosis of Guillain-Barr\u00e9 syndrome. Ann Neurol 1978;3:565-6. https:\/\/doi.org\/10.1002\/ana.410030628.","DOI":"10.1002\/ana.410030628"},{"key":"10.1016\/j.jocn.2021.07.025_b0090","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2021.07.025_b0095","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/ana.410350510","article-title":"N-acetylgalactosaminyl Gao is a target molecule for serum antibody in Guillain-Barr\u00e9 syndrome","volume":"35","author":"Kusunoki","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2021.07.025_b0100","doi-asserted-by":"crossref","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences (2nd ed.). New York: Routledge; 1988. https:\/\/doi.org\/10.4324\/9780203771587.","DOI":"10.4324\/9780203771587"},{"key":"10.1016\/j.jocn.2021.07.025_b0105","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s00415-016-8192-2","article-title":"Serial electrophysiological findings in Guillain-Barr\u00e9 syndrome not fulfilling AIDP or AMAN criteria","volume":"263","author":"Hosokawa","year":"2016","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2021.07.025_b0110","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/jnnp-2013-306509","article-title":"A multicentre prospective study of Guillain-Barr\u00e9 syndrome in Japan: a focus on the incidence of subtypes","volume":"86","author":"Mitsui","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2021.07.025_b0115","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/mus.25266","article-title":"Anti-ganglioside antibodies in Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyneuropathy in Chinese patients","volume":"55","author":"Fan","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2021.07.025_b0120","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/jnnp-2011-300309","article-title":"Antiganglioside antibodies are associated with axonal Guillain-Barr\u00e9 syndrome: A Japanese-Italian collaborative study","volume":"83","author":"Sekiguchi","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2021.07.025_b0125","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/jnnp.54.9.768","article-title":"Patterns and severity of conduction abnormalities in Guillain-Barr\u00e9 syndrome","volume":"54","author":"Brown","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2021.07.025_b0130","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/jnnp.68.2.191","article-title":"Isolated absence of F waves and proximal axonal dysfunction in Guillain-Barr\u00e9 syndrome with antiganglioside antibodies","volume":"68","author":"Kuwabara","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2021.07.025_b0135","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1212\/WNL.40.12.1900","article-title":"Acute axonal polyneuropathy associated with anti-GM1 antibodies flowing Camplylobacter enteritis","volume":"40","author":"Yuki","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2021.07.025_b0140","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/brain\/awf272","article-title":"Peripheral neuropathies and anti-glycolipid antibodies","volume":"125","author":"Willison","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2021.07.025_b0145","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/brain\/123.1.116","article-title":"Guillain-Barr\u00e9 syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a","volume":"123","author":"Kaida","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2021.07.025_b0150","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/mus.880160610","article-title":"Association of IgG anti-GD1a antibody with severe Guillain-Barr\u00e9 syndrome","volume":"16","author":"Yuki","year":"1993","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2021.07.025_b0155","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6","article-title":"Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barr\u00e9 syndrome","volume":"45","author":"Ho","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2021.07.025_b0160","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s004150070160","article-title":"Elevation in anti-GQ1b, anti-GT1a, and GT1b IgG antibodies in postinfectious acute ataxic neuropathy with oropharyngeal palsy but without ophthalmoplegia","volume":"247","author":"Kamakura","year":"2000","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2021.07.025_b0165","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1136\/jnnp-2020-323960","article-title":"Serum IgG anti-GD1a antibody and mEGOS predict outcome in Guillain-Barr\u00e9 syndrome","volume":"91","author":"Yamagishi","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2021.07.025_b0170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jns.2013.11.016","article-title":"Clinical feature in Guillain-Barr\u00e9 syndrome with anti-Gal-C antibody","volume":"337","author":"Samukawa","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jocn.2021.07.025_b0175","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jneuroim.2011.08.016","article-title":"Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyneuropathy","volume":"239","author":"Kuwahara","year":"2011","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jocn.2021.07.025_b0180","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1212\/WNL.51.6.1656","article-title":"Two patterns of clinical recovery in Guillain-Barr\u00e9 syndrome with IgG anti-GM1 antibody","volume":"51","author":"Kuwabara","year":"1998","journal-title":"Neurology"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586821003763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586821003763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:29:22Z","timestamp":1760822962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586821003763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":36,"alternative-id":["S0967586821003763"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2021.07.025","relation":{},"ISSN":["0967-5868"],"issn-type":[{"type":"print","value":"0967-5868"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unclassified subtype of Guillain-Barr\u00e9 syndrome is associated with quick recovery","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2021.07.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}